Company / R&D per Share
PRECIGEN, INC. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.14
FY2025
5-year range
$0.14 / $0.14
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#197 of 208
Health Care
What the data says
Among 208 Health Care companies, PRECIGEN, INC. is in the bottom 5% for r&d per share. Declined from $1.21 to $0.14 over the past 8 years.
Based on SEC 10-K filings.
0.14 in FY2025.
Declined from $1.21 to $0.14 over the past 8 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 208This company $0.14 Sector average $12.19
▼
-98.8% below sector average
Key checks
Key Insights
- Ranks #197 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -14.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.14 | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $3.31 | +174.7% |
| FY2017 | $1.21 | +25.5% |
| FY2016 | $0.96 | +100.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026